SBIR-STTR Award

PHS2019-02 Omnibus Solic of the NIH, CDC, and FDA for SBIR Apps No Clinical Trial (Parent SBIR R43/4
Award last edited on: 12/30/2023

Sponsored Program
SBIR
Awarding Agency
NIH : NCEZID
Total Award Amount
$972,102
Award Phase
2
Solicitation Topic Code
061
Principal Investigator
Steven A Benner

Company Information

Firebird Biomolecular Sciences LLC

Progress Boulevard
Alachua, FL 32615
   (386) 418-0347
   support@firebirdbio.com
   www.firebirdbio.com
Location: Single
Congr. District: 03
County: Alachua

Phase I

Contract Number: N/A
Start Date: 9/1/2021    Completed: 8/31/2023
Phase I year
2020
Phase I Amount
$1
Direct to Phase II

Phase II

Contract Number: 1R44CK000578-01
Start Date: 9/1/2021    Completed: 8/31/2023
Phase II year
2020
(last award dollars: 2022)
Phase II Amount
$972,101

Data not available. Public Health Relevance Statement Field Detection of arboviruses directly from mosquito traps Firebird Biomolecular Sciences, LLC. Narrative The NCEZID noted that "each year, scientists discover about two new mosquito-transmitted viruses that can make people sick." It therefore seeks small businesses to deliver products that survey environments for these viruses in multiplexed and flexible ways. In addition to supporting public heath efforts to predict and manage disease outbreaks, surveillance ensures that before damages are caused by spraying, some benefit is likely to emerge. Thus the CDC, the EPA, and their counterparts overseas all strongly recommend comprehensive mosquito surveillance; Florida law requires it before spraying. Phase 1 results have attracted the attention of the instrument-maker TrakitNow, whose award winning Moskeet platform counts and speciates mosquitoes, incorporates multiple information sources such as weather to guide PHS response, interacts with social networks, and does everything except extract a sample from potentially infected mosquitoes and examine it for viruses. If successful, this project will complete this surveillance platform, allowing PHS and private entities to move smoothly from the trapping of mosquitoes through to reporting of presence of mosquito-borne pathogens over times ranging from days to weeks, either under an operational architecture where an attendant visits a trap and PCR amplifies the trapped viral RNA (e.g., using an Insilixa device, operational architecture 1, OA1) or robotically performs those amplification (operational architecture 2, OA2). Project Terms No Project Terms available.